共 17 条
[3]
FUJIMOTO S, 1982, CANCER CHEMOTH PHARM, V8, P157
[4]
HPLC DETERMINATION OF MITOXANTRONE IN BIOLOGICAL-FLUIDS - A SENSITIVE AND ACCURATE METHOD
[J].
JOURNAL OF HIGH RESOLUTION CHROMATOGRAPHY & CHROMATOGRAPHY COMMUNICATIONS,
1983, 6 (09)
:512-513
[5]
JOHNSON RK, 1979, CANCER TREAT REP, V63, P425
[6]
NEIDHART JA, 1982, P AM SOC CLIN ONCOL, V23, P86
[7]
AN HPLC METHOD FOR THE QUANTITATIVE-DETERMINATION OF 1,4-DIHYDROXY-5,8 BIS [[2-[(2-HYDROXYETHYL)AMINO]ETHYL]AMINO]9,10-ANTHRACENEDIONE (DHAQ, LEDERLE LABS CL232315, NCS 301739) IN SERUM
[J].
JOURNAL OF LIQUID CHROMATOGRAPHY,
1980, 3 (05)
:637-644
[8]
IMPROVED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF THE NEW ANTI-NEOPLASTIC AGENTS BISANTRENE AND MITOXANTRONE
[J].
JOURNAL OF CHROMATOGRAPHY,
1982, 233 (DEC)
:235-247
[10]
CLINICAL ANALYSIS FOR THE ANTI-NEOPLASTIC AGENT 1,4-DIHYDROXY-5,8-BIS((2-[(2-HYDROXYETHYL)AMINO]ETHYL)-AMINO) 9,10-ANTHRACENEDIONE DIHYDROCHLORIDE (NSC 301739) IN PLASMA - APPLICATION OF TEMPERATURE CONTROL TO PROVIDE SELECTIVITY IN PAIRED-ION HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
[J].
JOURNAL OF CHROMATOGRAPHY,
1981, 222 (02)
:225-240